BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 2265709)

  • 1. Inhibition of insulin secretion by interleukin-1 beta and tumour necrosis factor-alpha via an L-arginine-dependent nitric oxide generating mechanism.
    Southern C; Schulster D; Green IC
    FEBS Lett; 1990 Dec; 276(1-2):42-4. PubMed ID: 2265709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nitric oxide mediates cytokine-induced inhibition of insulin secretion by human islets of Langerhans.
    Corbett JA; Sweetland MA; Wang JL; Lancaster JR; McDaniel ML
    Proc Natl Acad Sci U S A; 1993 Mar; 90(5):1731-5. PubMed ID: 8383325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A 1-hour pulse with IL-1 beta induces formation of nitric oxide and inhibits insulin secretion by rat islets of Langerhans: evidence for a tyrosine kinase signaling mechanism.
    Corbett JA; Sweetland MA; Lancaster JR; McDaniel ML
    FASEB J; 1993 Feb; 7(2):369-74. PubMed ID: 8440413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-1 beta-induced formation of EPR-detectable iron-nitrosyl complexes in islets of Langerhans. Role of nitric oxide in interleukin-1 beta-induced inhibition of insulin secretion.
    Corbett JA; Lancaster JR; Sweetland MA; McDaniel ML
    J Biol Chem; 1991 Nov; 266(32):21351-4. PubMed ID: 1657959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nicotinamide prevents interleukin-1 effects on accumulated insulin release and nitric oxide production in rat islets of Langerhans.
    Andersen HU; Jørgensen KH; Egeberg J; Mandrup-Poulsen T; Nerup J
    Diabetes; 1994 Jun; 43(6):770-7. PubMed ID: 8194662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-1 beta-induced nitric oxide production in isolated rat pancreatic islets requires gene transcription and may lead to inhibition of the Krebs cycle enzyme aconitase.
    Welsh N; Eizirik DL; Bendtzen K; Sandler S
    Endocrinology; 1991 Dec; 129(6):3167-73. PubMed ID: 1720090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of insulin secretion from rat islets of Langerhans by interleukin-6. An effect distinct from that of interleukin-1.
    Southern C; Schulster D; Green IC
    Biochem J; 1990 Nov; 272(1):243-5. PubMed ID: 2264829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-1 beta effects on cyclic GMP and cyclic AMP in cultured rat islets of Langerhans-arginine-dependence and relationship to insulin secretion.
    Green IC; Delaney CA; Cunningham JM; Karmiris V; Southern C
    Diabetologia; 1993 Jan; 36(1):9-16. PubMed ID: 7679657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor necrosis factor-alpha and interferon-gamma inhibit insulin secretion and cause DNA damage in unweaned-rat islets. Extent of nitric oxide involvement.
    Dunger A; Cunningham JM; Delaney CA; Lowe JE; Green MH; Bone AJ; Green IC
    Diabetes; 1996 Feb; 45(2):183-9. PubMed ID: 8549863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytokines suppress human islet function irrespective of their effects on nitric oxide generation.
    Eizirik DL; Sandler S; Welsh N; Cetkovic-Cvrlje M; Nieman A; Geller DA; Pipeleers DG; Bendtzen K; Hellerström C
    J Clin Invest; 1994 May; 93(5):1968-74. PubMed ID: 7514190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nitric oxide and cyclic GMP formation induced by interleukin 1 beta in islets of Langerhans. Evidence for an effector role of nitric oxide in islet dysfunction.
    Corbett JA; Wang JL; Hughes JH; Wolf BA; Sweetland MA; Lancaster JR; McDaniel ML
    Biochem J; 1992 Oct; 287 ( Pt 1)(Pt 1):229-35. PubMed ID: 1384465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin 1 beta induces the formation of nitric oxide by beta-cells purified from rodent islets of Langerhans. Evidence for the beta-cell as a source and site of action of nitric oxide.
    Corbett JA; Wang JL; Sweetland MA; Lancaster JR; McDaniel ML
    J Clin Invest; 1992 Dec; 90(6):2384-91. PubMed ID: 1334975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-1 beta induces nitric oxide production and inhibits the activity of aconitase without decreasing glucose oxidation rates in isolated mouse pancreatic islets.
    Welsh N; Sandler S
    Biochem Biophys Res Commun; 1992 Jan; 182(1):333-40. PubMed ID: 1731791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-1β hampers glucose-stimulated insulin secretion in Cohen diabetic rat islets through mitochondrial cytochrome c oxidase inhibition by nitric oxide.
    Weksler-Zangen S; Aharon-Hananel G; Mantzur C; Aouizerat T; Gurgul-Convey E; Raz I; Saada A
    Am J Physiol Endocrinol Metab; 2014 Mar; 306(6):E648-57. PubMed ID: 24425765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of interleukin 1-induced apoptosis in rat islets using in situ specific labelling of fragmented DNA.
    Dunger A; Augstein P; Schmidt S; Fischer U
    J Autoimmun; 1996 Jun; 9(3):309-13. PubMed ID: 8816965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nicotinamide partially reverses the interleukin-1 beta inhibition of glucose-induced insulin release in pancreatic islets.
    Buscema M; Vinci C; Gatta C; Rabuazzo MA; Vignen R; Purrello F
    Metabolism; 1992 Mar; 41(3):296-300. PubMed ID: 1531861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of nitric oxide in IL-1 beta-mediated dysfunction of rodent islets of Langerhans. Implications for the function of intrahepatic islet grafts.
    Xenos ES; Stevens RB; Sutherland DE; Lokeh A; Ansite JD; Casanova D; Gores PF; Platt JL
    Transplantation; 1994 Apr; 57(8):1208-12. PubMed ID: 8178348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reversibility of interleukin-1 beta-induced islet destruction and dysfunction by the inhibition of nitric oxide synthase.
    Corbett JA; McDaniel ML
    Biochem J; 1994 May; 299 ( Pt 3)(Pt 3):719-24. PubMed ID: 7514870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-1 beta-induced inhibition of beta-cell function is mediated through nitric oxide.
    Xenos ES; Stevens RB; Gores PF; Casanova D; Farney AC; Sutherland DE; Platt JL
    Transplant Proc; 1993 Feb; 25(1 Pt 2):994. PubMed ID: 7680174
    [No Abstract]   [Full Text] [Related]  

  • 20. S-methyl-L-thiocitrulline counteracts interleukin 1 beta induced suppression of pancreatic islet function in vitro, but does not protect against multiple low-dose streptozotocin-induced diabetes in vivo.
    Sternesjö J; Welsh N; Sandler S
    Cytokine; 1997 May; 9(5):352-9. PubMed ID: 9195135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.